xylazine has been researched along with Demyelinating Diseases in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heckl, S | 1 |
| Nägele, T | 1 |
| Herrmann, M | 1 |
| Gärtner, S | 1 |
| Klose, U | 1 |
| Schick, F | 1 |
| Weissert, R | 1 |
| Küker, W | 1 |
1 other study available for xylazine and Demyelinating Diseases
| Article | Year |
|---|---|
Experimental autoimmune encephalomyelitis (EAE): lesion visualization on a 3 Tesla clinical whole-body system after intraperitoneal contrast injection.
Topics: Adrenergic alpha-Agonists; Anesthetics, Dissociative; Animals; Brain; Brain Stem; Cerebellum; Contra | 2004 |